Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular Diseases

  • ACS Med Chem Lett. 2024 Jul 11;15(8):1184-1185. doi: 10.1021/acsmedchemlett.4c00304.
Ram W Sabnis  1
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 39140065 DOI: 10.1021/acsmedchemlett.4c00304
Abstract

Provided herein are novel compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such compounds in treating cardiovascular diseases, and processes for preparing such compounds.

Products